Vinay Prasad, a renowned oncologist-hematologist, has been appointed as the new director of the Center for Biologics Evaluation and Research (CBER) at the US Food and Drug Administration (FDA). This division of the FDA is charged with overseeing the evaluation and approval of critical biologic products, including vaccines, blood derivatives, and select gene-based therapies. Prasad’s appointment comes at a time when the FDA remains under public and political scrutiny for its handling of

As Brain Cancer Awareness Month unfolds in May, a mother from the suburbs is speaking out about her experience with glioblastoma, one of the most aggressive forms of brain cancer. Her story is a call to action for early detection, self-advocacy, and access to advanced treatment options that are increasingly available beyond major city hospitals. An energetic and health-conscious mother of two, she first noticed something unusual in June 2024. While working, she felt pain in her